CRA experts advised two parties during both the CMA’s investigation and CAT Appeals, assessing the economic evidence and providing expert testimony on what prices could be considered excessive (or, to the contrary, consistent with competitive outcomes) in the UK market for Liothyronine tablets.
Merger enforcement policies of the second Trump Administration: Early developments and priorities
In the article published by the American Bar Association (ABA), “Merger Enforcement Policies of the Second Trump Administration: Early Developments and...